Non-Academic Senior Resident (Adhoc)
About this recruitment
Postgraduate Institute of Medical Education & Research, Chandigarh has issued an official recruitment notice for the post of Non-Academic Senior Resident (Adhoc). A total of 3 vacancies are advertised. The post sits in the Clinical Hematology & Medical Oncology department. MediJobs indexes this notice from the institution's own source and links to it; applications are made only on the official portal.
Posts advertised: Non-Academic Senior Resident (Adhoc) (3 posts).
Eligibility: A Medical qualification included in the first or second schedule or Part-II of the third schedule to the Indian Medical Council Act, 1956 (a person possessing qualifications included in the Part-II of the third schedule should also fulfil the conditions specified in Section 13 (3) of the Act). Must be registered with Central/State Medical Council. MD/DNB Medicine or MD Radiotherapy or MD/DNB Pediatrics (eligible for Medical Oncology only) or it's equivalent degree from university recognized by National Medical Council of India. Age limit: up to 45 years as stated in the notice. Registration: Must be registered with Central/State Medical Council.
Remuneration: As per PGI rules. The official notice is authoritative on pay.
The last date to apply is 2026-12-31. Candidates must apply through the official notification linked on this page. Government recruitment never charges a fee over messaging apps and never asks for payment in exchange for an offer letter.
At a glance
Roles & reservation
| Role | Total | UR | OBC | SC | ST | EWS | PwBD | Contract | Pay |
|---|---|---|---|---|---|---|---|---|---|
| Non-Academic Senior Resident (Adhoc) — Clinical Hematology & Medical Oncology | 3 | — | — | — | — | — | — | ad-hoc | As per PGI rules |
UR · Unreserved, OBC, SC, ST, EWS, PwBD as stated in the official notice. Verify category eligibility on the source document.
Government recruitment never asks for application fees over WhatsApp or for advance payment for an offer letter. Always apply only on the official portal linked above. Read our anti-fraud guidance.